维普期刊资源整合服务平台（V6.5）

102篇 您的检索式：作者名="Cesne"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HERI:A phase Ⅱ trial of EORTC Soft Tissue and Bone Sarcoma Group显示文摘	Blay J Le Cesne A Whelan J	2006	J Clin Oncol2006，24，：	1
2	Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial 显示文摘	Le Cesne A Ray-Coquard I Bui BN	2010	Lancet Oncol2010，11，10：	1
3	A phase Ⅱ study of gefitinib for patients with advanced her-1 expressing synovial sarcoma refractory,to doxorubicin-containing regimens显示文摘	Ray-Coquard I Le Cesne A Whelan JS	2008	Oncologist2008，13，4：	1
4	KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal turnouts 显示文摘	Rychtera MD Sciotb R Cesned AL	2006	European Journal of Cancer2006，42，8：	1
5	Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase 1I trial with a long- term follow-up显示文摘	Penel N Le Cesne A Bui BN	2011	Ann Oncol2011，22，2：	1
6	Prospective multi-centric randomized phase HI study of imatinib in patients withadvanced gastrointestinal stromal tumors comparing interrup-tion versus continuation of treatment beyond 1 year: TheFrench Sarcoma Group 显示文摘	Blay JY Le Cesne A Ray-Coquard I	2007	J Clin Oncol2007，25，9：	1
7	Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG) 显示文摘	Garhay D Le Cesne A Penel N	2012	Ann Oncol2012，23，1：	1
8	Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients显示文摘	Fran?ois Ghiringhelli Cedric Menard Pierre Emmanuel Puig Sylvain Ladoire Stephan Roux Fran?ois Martin Eric Solary Axel Le Cesne Laurence Zitvogel Bruno Chauffert	2007	Cancer Immunology Immunotherapy2007，，5：	1
9	KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours 显示文摘	Debiec-Rychter M Sciot R Le Cesne A	2006	Eur J Cancer2006，42，：	1
10	Clear cell sarcoma(malignant melanoma) of soft parts: a clinicopathologic study of52 cases 显示文摘	Hocar 0 Le Cesne A Berissi S	2012	Dermatol Res Pract2012，2012，98：	1
11	Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era显示文摘	S. Bonvalot H. Eldweny C. Le Péchoux D. Vanel P. Terrier A. Cavalcanti C. Robert N. Lassau A. Le Cesne	2006	Annals of Surgical Oncology2006，，12：	1
12	KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours显示文摘	Debiec-Rychter M Sciot R Le cesne A	2006	Eur J Cancer2006，42，8：	1
13	Surgical excision of bone sarcomas involving the sacroiliac joint显示文摘	Court C Bosca L Cesne A Le		0，，05：	1
14	Kit mutations and close selection for imatinib in patients with advanced gastrointestinal stromal tumours 显示文摘	Debiec-Rychter M Sciot R Le Cesne A	2006	Eur J Cancer2006，42，8：	1
15	Prospective multicentric randomized phase III study of imatinib in patients vdth advanced gas- trointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year:the French Sarcoma Group显示文摘	Blay JY Le Cesne A Ray-Coquard 1	2007	J Clin Oncol2007，25，9：	1
16	Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis显示文摘	Dufresne A Bertucci F Penel N Le Cesne A Bui B Tubiana-Hulin M Ray-Coquard I Cupissol D Chevreau C Perol D Goncalves A Jimenez M Bringuier PP Blay JY	2010	Br J Cancer2010，103，4：	1
17	KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours显示文摘	Debiec-Rychter M Sciot R Le Cesne A	2006	Eur J Cancer2006，42，8：	1
18	Lymphopenia as a prognostic factor for overall survival in advanced carcinomas,sarcomas,and lymphomas显示文摘	Ray-Coquard I Cropet C Van Glabbeke M Sebban C Le Cesne A Judson I Tredan O Verweij J Biron P Labidi I Guastalla JP Bachelot T Perol D Chabaud S Hogendoorn PCW Cassier P Dufresne A Blay JY	2009	Cancer Res2009，69，13：	1
19	Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neu- tropenia 显示文摘	Blay JY Chauvin F Le Cesne A	1996	J Clin Oncol1996，14，2：	1
20	Sorafenib in patients with progressive epithelioid hemangioendothelioma显示文摘	Christine Chevreau Axel Le Cesne Isabelle Ray‐Coquard Antoine Italiano Angela Cioffi Nicolas Isambert Yves Marie Robin Charles Fournier Stéphanie Clisant Loic Chaigneau Jacques‐Olivier Bay Emmanuelle Bompas Eric Gauthier Jean Y. Blay Nicolas Penel	2013	Cancer2013，，14：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示